Accounts Payable

6 Months Ended

Jun. 30, 2015

Accounts Payable Disclosure [Abstract]

Accounts Payable

3. Accounts Payable

As of June 30, 2015, Current Liabilities included accounts payable of $385,073 comprised primarily of amounts owed to the Company’s drug product manufacturers and raw materials suppliers. By the first week of August 2015, the June 30, 2015 amounts included in accounts payable had been substantially paid. As of December 31, 2014, Current Liabilities included accounts payable of $41,026 and accounts payable – related party of $100,450 for MD Anderson clinical trial hospital expense which had been substantially paid by the first week of May 2015. MD Anderson is no longer a greater than 5% stockholder in the Company. As a result, the Company has consolidated accounts payable with accounts payable – related party on the financial statements beginning in 2015.